Key Market Indicators
Norwegian sales of beta blocking medicine are expected to reach $20 million by 2026. In 2021, the country totaled $22.5 million in sales, a 1.8% dip from the previous year. Since 2007, Norway's market has grown by an average of 1% each year. In 2021, it ranked 18th, with Ireland coming in first at $22.5 million. Italy, Canada and Australia followed at second, third and fourth, respectively.
